Opioid use disorder and misuse: A review of the epidemiology and medical implications for pediatric anesthesiologists.
Emily Knipper, Caleb J Banta-Green, Nathalia Jimenez
https://pubmed.ncbi.nlm.nih.gov/29030938/Actively Recruiting
Led by Children's Healthcare of Atlanta · Updated on 2019-07-24
50
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the use of gabapentin to reduce pain after tonsillectomy and adenoidectomy in children aged 3 to 18 years. This pilot study aims to see if a single preoperative dose of gabapentin decreases the amount of narcotic pain medicine needed in the first 48 hours after surgery. It also compares the timing of the first pain medicine dose and pain scores at 12, 24, and 48 hours after surgery using pain scales like Wong Baker and a numeric distress scale. In this double-blind randomized controlled trial, 50 children undergoing tonsillectomy and adenoidectomy will be randomly assigned to receive either one dose of gabapentin 15 mgkg up to 600 mg or a placebo before surgery. Both groups will receive the usual narcotic pain treatment during surgery. After surgery, younger children will be guided to take Tylenol and Motrin, while teenagers will get a narcotic prescription. The study will measure the amount of each pain medicine used and the time to first pain medicine. Participants will be monitored through phone calls with a research nurse for three days after surgery to collect pain scores at specified times. Researchers will track the total narcotic consumption during the first 48 hours after surgery as the main outcome. The study also looks at the timing of the first pain medicine and pain levels at 12, 24, and 48 hours. This detailed follow-up helps evaluate how gabapentin affects pain control in children after these common surgeries.
CONDITIONS
Gabapentin Premedication to Reduce Postoperative Pain for Pediatric Tonsillectomy
B
Beena Desai
M
Margaret A Gettis, DNP,CPNP-PC
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Children's Healthcare of Atlanta
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Gabapentin premedication | Placebo control | Acetaminophen + NSAIDs (current standard care) |
|---|---|---|---|
| What it is | Preoperative single oral dose of gabapentin (15 mg/kg, max 600 mg) plus standard intraoperative narcotic regimen | Preoperative oral placebo plus the same standard intraoperative narcotic regimen | Outpatient post‑tonsillectomy pain is typically managed with acetaminophen and nonsteroidal anti‑inflammatory drugs |
| Role in trial | Investigational arm receiving gabapentin | Control arm receiving placebo | Represents current usual care outside the trial |
| Purpose | Evaluate whether gabapentin reduces postoperative narcotic use and pain after tonsillectomy in children | Serve as comparator to assess gabapentin effect | Reflect reference outpatient analgesic practices for context |
| Administration | Single oral dose before anesthesia, followed by standard narcotic usage intraoperatively | Single oral placebo before anesthesia, same intraoperative narcotic usage | Pain relief typically with scheduled acetaminophen and NSAIDs after surgery |
| Evidence status | Effectiveness for reducing postoperative opioid use and pain is under investigation in this trial | Placebo has no therapeutic effect by design | Multimodal analgesia including acetaminophen and NSAIDs is widely used and supported in pediatric tonsillectomy to reduce opioid use |
| Important risks | Safety in children appears acceptable in prior studies but remains under evaluation | No active drug, risks limited to standard perioperative procedures | Acetaminophen and NSAIDs are generally safe but carry risks such as liver effects (acetaminophen) or bleeding (NSAIDs) when used post‑tonsillectomy |
| Important limitations | Results pending; off‑label use in children; pain reduction effectiveness and safety not yet confirmed | Inherently addresses only trial internal comparison and does not reflect real‑world care | Evidence comes from meta‑analyses and reviews but may not reflect specific effectiveness in all settings |
| Patient impact | Not yet established—impact on pain relief or recovery remains pending trial results | Expected no benefit in pain reduction, beyond standard intraoperative care | Established practice linked to improved postoperative comfort and decreased opioid needs in many pediatric settings |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day of surgery
Participants receive either a single dose of gabapentin or placebo before surgery, followed by standard narcotic pain management during tonsillectomy or adenoidectomy surgery.
1 visit (preoperative dosing and surgery)
Duration - 3 days postoperatively
Participants are followed up with phone interviews by a research nurse to assess pain scores and analgesic use for 3 days after surgery.
Phone interviews at 12, 24, and 48 hours postoperatively
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Emily Knipper, Caleb J Banta-Green, Nathalia Jimenez
https://pubmed.ncbi.nlm.nih.gov/29030938/Cornelius A Thiels, Stephanie S Anderson, Daniel S Ubl...
https://pubmed.ncbi.nlm.nih.gov/28697049/Soroush Amani, Mohamad Reza Abedinzadeh
https://pubmed.ncbi.nlm.nih.gov/26568937/Se Hwan Hwang, In Joon Park, Young Jin Cho...
https://pubmed.ncbi.nlm.nih.gov/26404562/Sabry Mohammad Amin
https://pubmed.ncbi.nlm.nih.gov/25191179/Sabry M Amin, Yasser M Amr
https://pubmed.ncbi.nlm.nih.gov/25885382/Children's Healthcare of Atlanta
Lead Sponsor